» Authors » Ilona Krol

Ilona Krol

Explore the profile of Ilona Krol including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 1838
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Vetter M, Landin J, Szczerba B, Castro-Giner F, Gkountela S, Donato C, et al.
Breast Cancer Res . 2018 Nov; 20(1):141. PMID: 30458879
Background: The presence of circulating tumor cells (CTCs) in patients with breast cancer correlates to a bad prognosis. Yet, CTCs are detectable in only a minority of patients with progressive...
12.
Krol I, Castro-Giner F, Maurer M, Gkountela S, Szczerba B, Scherrer R, et al.
Br J Cancer . 2018 Aug; 119(4):487-491. PMID: 30065256
Human glioblastoma (GBM) is a highly aggressive, invasive and hypervascularised malignant brain cancer. Individual circulating tumour cells (CTCs) are sporadically found in GBM patients, yet it is unclear whether multicellular...
13.
Bernsmeier C, Dill M, Provenzano A, Makowska Z, Krol I, Muscogiuri G, et al.
Lab Invest . 2016 Jul; 96(9):972-80. PMID: 27428080
Notch signaling pathways have recently been implicated in the pathogenesis of metabolic diseases. However, the role of hepatic Notch signaling in glucose and lipid metabolism remains unclear and needs further...
14.
Terczynska-Dyla E, Bibert S, Duong F, Krol I, Jorgensen S, Collinet E, et al.
Nat Commun . 2015 Jun; 6:7280. PMID: 26118470
No abstract available.
15.
Krol J, Krol I, Alvarez C, Fiscella M, Hierlemann A, Roska B, et al.
Nat Commun . 2015 Jun; 6:7305. PMID: 26041499
Brain regions, such as the cortex and retina, are composed of layers of uniform thickness. The molecular mechanism that controls this uniformity is not well understood. Here we show that...
16.
Terczynska-Dyla E, Bibert S, Duong F, Krol I, Jorgensen S, Collinet E, et al.
Nat Commun . 2014 Dec; 5:5699. PMID: 25534433
Hepatitis C virus (HCV) infections are the major cause of chronic liver disease, cirrhosis and hepatocellular carcinoma worldwide. Both spontaneous and treatment-induced clearance of HCV depend on genetic variation within...
17.
Duong F, Trincucci G, Boldanova T, Calabrese D, Campana B, Krol I, et al.
J Exp Med . 2014 Apr; 211(5):857-68. PMID: 24752298
The molecular mechanisms that link IFN-λ3 genotypes to differential induction of interferon (IFN)-stimulated genes (ISGs) in the liver of patients with chronic hepatitis C (CHC) are not known. We measured...
18.
Dill M, Makowska Z, Trincucci G, Gruber A, Vogt J, Filipowicz M, et al.
J Clin Invest . 2014 Feb; 124(4):1568-81. PMID: 24569457
The use of pegylated interferon-α (pegIFN-α) has replaced unmodified recombinant IFN-α for the treatment of chronic viral hepatitis. While the superior antiviral efficacy of pegIFN-α is generally attributed to improved...